Renal Transplant
84
5
6
52
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
15 trials with published results (18%)
Research Maturity
52 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.8%
4 terminated out of 84 trials
92.9%
+6.4% vs benchmark
31%
26 trials in Phase 3/4
29%
15 of 52 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 52 completed trials
Clinical Trials (84)
Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™
Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN
Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney Transplantation
Does Early Postoperative Fluid Management Affect Functional Delayed Graft Function After Living Donor Kidney Transplantation?
Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany
Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients
Frailty Among Renal Transplant Recipients and Relation to Chronic Allograft Dysfunction
Early Pharmacological and Immune Monitoring After Conversion to Belatacept in Renal Transplant Patients
A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma
NEgative prEssure Wound Therapy in Renal Transplant
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Efficacy of the ALL YOU NEED is LOVE Healthcare Transition Syllabus Among Pre- and Posttransplant Adolescents in Cali, Colombia
Kidney Transplant Low-AGE Diet Study
A Study of the Correlation Between Donor UDP-Glc and Transplanted Kidney Function
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes
Characterization Of the Intestinal Microbiome Evolution After Kidney Transplant Donation or Receipt
AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce
Influence of the Intestinal Microbiota on the Clinical Course of Renal Transplantation
Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients